Michelle A. Peluso - Apr 1, 2023 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP and Co-President of Retail
Signature
/s/ Michelle A. Peluso
Stock symbol
CVS
Transactions as of
Apr 1, 2023
Transactions value $
-$685,584
Form type
4
Date filed
4/4/2023, 04:35 PM
Previous filing
Mar 1, 2023
Next filing
Sep 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Tax liability -$7.3M -98.3K -44.14% $74.31 124K Apr 1, 2023 Direct F1
holding CVS Common Stock (Restricted) 55K Apr 1, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Stock Option Award $6.62M +89.1K $74.31 89.1K Apr 1, 2023 Common Stock 89.1K $74.31 Direct F4
holding CVS Stock Option 86.4K Apr 1, 2023 Common Stock 86.4K $74.30 Direct F2
holding CVS Stock Option 57.2K Apr 1, 2023 Common Stock 57.2K $101.09 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Surrender of shares in payment of withholding taxes due upon the vesting and settlement of a performance stock unit award.
F2 Option became exercisable in four equal annual installments, commencing 4/1/2022.
F3 Option became exercisable in four equal annual installments, commencing 4/1/2023.
F4 Option becomes exercisable in four equal annual installments, commencing 4/1/2024.